SCG Cell Therapy Announces U.S FDA Clearance of Investigational New Drug Application for SCG101, SCG’s Novel TCR-T Cell Therapy For Hepatitis B-related Liver Cancers
SINGAPORE, July 11, 2022 /PRNewswire/ -- Singapore-based SCG Cell Therapy Pte Ltd ("SCG") announced that U.S. Food and Drug Administration (FDA) has cleared the Investigational New Drug (IND) application for SCG101, an investigational T-cell receptor (TCR) T cell therapy for patients with hepatitis B virus (HBV) related liver cancer. This clearance initiates the advancement of SCG101 Phase 1/2 clinical trials...
ZIRCON Phase III Kidney Cancer Imaging Study Completes Enrolment
MELBOURNE, Australia, July 11, 2022 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces that it has dosed the final patient and completed recruitment into the Phase III pivotal study ZIRCON (Zirconium in Renal Cancer Oncology, NCT03849118) of its investigational renal (kidney) cancer imaging agent TLX250-CDx (89Zr-DFO-girentuximab). This global study...
Kevin Richardson appointed as CEO, Telix Americas
MELBOURNE and INDIANAPOLIS, July 11, 2022 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) is pleased to announce that Kevin Richardson, a senior global executive with a career focus on sales, marketing and business operations in the oncology and radiopharmaceutical markets, will commence in the role of CEO, Telix Americas, on 11...
CORDIS NAMES BRYAN LOO PRESIDENT OF ASIA-PACIFIC REGION
Seasoned medical technology leader tapped to maximize momentum in APAC MIAMI LAKES, Fla., July 8, 2022 /PRNewswire/ -- Cordis, a global leader in cardiovascular technologies, today announced that Bryan Loo will assume the role of President of the Asia-Pacific (APAC) region effective July 18, 2022. Loo will head a leadership team responsible for...
Zibo, Shandong, accelerates its transformation into the biggest pre-prepared food industrial base in northern China
ZIBO, China, July 8, 2022 /PRNewswire/ -- Themed along the lines of building a better future for the pre-prepared food industry and for enjoying the uniquely-flavored Zibo cuisine, the 2022 China (Shandong) Pre-prepared Food Industry Development Conference hosted by the Shandong Provincial Department of Commerce, the People's Government of Zibo, and the China Pre-prepared Food Industry Alliance was recently...
Industry Empowered by Science: Guangming Science City Lures Talent Globally
SHENZHEN, China, July 8, 2022 /PRNewswire/ -- The 8th Shenzhen Global Shenzhen Entrepreneurs Convention and Guangming Science City Conference kicked off on July 5, and gathered global scientists and leading entrepreneurs together to the southern Chinese city. They're invited to share their perspectives on how the Guangming Science City will embrace a bright future in terms of the innovation...
Biotech Startup Noul Releases 2021 Sustainability Report
Disclose achievement and improvement on economic, social, and environmental commitments Contain corporate will to take sustainability as its management philosophy since its foundation Write based on the GRI standards and self-disclose to the DART electronic disclosure system YONGIN, South Korea, July 8, 2022 /PRNewswire/ -- Noul Co., Ltd., (376930.KR), a KOSDAQ-listed...
HKUMed and CityU Scientists Discover Non-invasive Stimulation of the Eye for Depression and Dementia
HONG KONG, July 8, 2022 /PRNewswire/ -- A joint research team from Li Ka Shing Faculty of Medicine, The University of Hong Kong (HKUMed) and City University of Hong Kong (CityU) has discovered that electrical stimulation of the eye surface can alleviate depression-like symptoms and improve cognitive function in animal models. (L-R) Prof. Chan...
iGene Laboratory launches Monkeypox PCR test for the South East Asian region.
SINGAPORE, July 8, 2022 /PRNewswire/ -- iGene Laboratory, the molecular diagnostics laboratory subsidiary of INEX Innovate Pte Ltd, announces the launch of its research-use-only (RUO) polymerase chain reaction (PCR) Monkeypox test in response to the recent outbreak of the virus. The iGene Laboratory team The Monkeypox...
NEW EARLY BREAST CANCER DRUG TO REDUCE RISK OF RECURRENCE OR DEATH NOW AVAILABLE IN THE PHILIPPINES
NERLYNX® (neratinib) is approved by the Food and Drug Administration of the Philippines Leading regional breast cancer oncologists say the availability of NERLYNX is a 'great step forward' for women in the Philippines who have been diagnosed with HER2+ early-stage breast cancer Five-year follow-up data shows NERLYNX reduces the risk of invasive disease recurrence by...
